tnf α neutralizing antibody 197 Search Results


apc anti human tnfα  (Miltenyi Biotec)
93
Miltenyi Biotec apc anti human tnfα
A. Heatmap showing scaled expression values of discriminative gene sets between CD8_2 (exhaustion-like) and CD8_4+6 (memory/effector-like) using original unsorted, and sorted (CD39+TIM3+ and CD39−TIM3−) cells. B. Heatmap of scaled expression values of discriminative gene sets between sorted CD39+TIM3+CD8+ and CD39−TIM3−CD8+ T cells. Colored bars above heatmap show the CD8+ cluster (as in Figure 4A) in which the gene is enriched C. Representative flow cytometry plots for intracellular staining of IL-2, IFNγ and <t>TNFα</t> in CD39− and CD39+ cells, with quantification below for 12 patients. Data were combined from 2 replicate experiments. D. Quantification of live/dead cells based on staining of CT26GFP+ MDOTS on day 5 of ex vivo culture. One of two independent experiments is shown, with n=3 replicates per group per experiment. 2-way ANOVA, Tukey’s multiple comparisons test. E. A schematic summary of the therapy regimen used in the transplantable B16-F10 mouse model. F. Tumor volumes for all 4 groups. G. Survival of B16-F10 tumor-bearing mice treated with CD39i in combination with anti-TIM3. H. Tumor volumes for untreated, anti-PD-1, CD39i and anti-PD-1+CD39i treated groups. I. Survival of B16-F10 tumor-bearing mice treated with CD39i + anti-PD-1. J. Tumor volumes for untreated, anti-PD-1/CTLA4, CD39i, anti-PD-1/CTLA4+CD39i. K. Survival of B16-F10 tumor-bearing mice treated with CD39i and anti-PD-1/CTLA4. Data are represented as mean±SEM. For in vivo mouse tumor models one of two independent experiments is shown.
Apc Anti Human Tnfα, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/apc anti human tnfα/product/Miltenyi Biotec
Average 93 stars, based on 1 article reviews
apc anti human tnfα - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
tnf α neutralizing antibody 197  (Bio-Rad)
93
Bio-Rad tnf α neutralizing antibody 197
A. Heatmap showing scaled expression values of discriminative gene sets between CD8_2 (exhaustion-like) and CD8_4+6 (memory/effector-like) using original unsorted, and sorted (CD39+TIM3+ and CD39−TIM3−) cells. B. Heatmap of scaled expression values of discriminative gene sets between sorted CD39+TIM3+CD8+ and CD39−TIM3−CD8+ T cells. Colored bars above heatmap show the CD8+ cluster (as in Figure 4A) in which the gene is enriched C. Representative flow cytometry plots for intracellular staining of IL-2, IFNγ and <t>TNFα</t> in CD39− and CD39+ cells, with quantification below for 12 patients. Data were combined from 2 replicate experiments. D. Quantification of live/dead cells based on staining of CT26GFP+ MDOTS on day 5 of ex vivo culture. One of two independent experiments is shown, with n=3 replicates per group per experiment. 2-way ANOVA, Tukey’s multiple comparisons test. E. A schematic summary of the therapy regimen used in the transplantable B16-F10 mouse model. F. Tumor volumes for all 4 groups. G. Survival of B16-F10 tumor-bearing mice treated with CD39i in combination with anti-TIM3. H. Tumor volumes for untreated, anti-PD-1, CD39i and anti-PD-1+CD39i treated groups. I. Survival of B16-F10 tumor-bearing mice treated with CD39i + anti-PD-1. J. Tumor volumes for untreated, anti-PD-1/CTLA4, CD39i, anti-PD-1/CTLA4+CD39i. K. Survival of B16-F10 tumor-bearing mice treated with CD39i and anti-PD-1/CTLA4. Data are represented as mean±SEM. For in vivo mouse tumor models one of two independent experiments is shown.
Tnf α Neutralizing Antibody 197, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/tnf α neutralizing antibody 197/product/Bio-Rad
Average 93 stars, based on 1 article reviews
tnf α neutralizing antibody 197 - by Bioz Stars, 2026-05
93/100 stars
  Buy from Supplier
anti-tnfα antibodies ebioscience #88-7346  (Thermo Fisher)
90
Thermo Fisher anti-tnfα antibodies ebioscience #88-7346
A. Heatmap showing scaled expression values of discriminative gene sets between CD8_2 (exhaustion-like) and CD8_4+6 (memory/effector-like) using original unsorted, and sorted (CD39+TIM3+ and CD39−TIM3−) cells. B. Heatmap of scaled expression values of discriminative gene sets between sorted CD39+TIM3+CD8+ and CD39−TIM3−CD8+ T cells. Colored bars above heatmap show the CD8+ cluster (as in Figure 4A) in which the gene is enriched C. Representative flow cytometry plots for intracellular staining of IL-2, IFNγ and <t>TNFα</t> in CD39− and CD39+ cells, with quantification below for 12 patients. Data were combined from 2 replicate experiments. D. Quantification of live/dead cells based on staining of CT26GFP+ MDOTS on day 5 of ex vivo culture. One of two independent experiments is shown, with n=3 replicates per group per experiment. 2-way ANOVA, Tukey’s multiple comparisons test. E. A schematic summary of the therapy regimen used in the transplantable B16-F10 mouse model. F. Tumor volumes for all 4 groups. G. Survival of B16-F10 tumor-bearing mice treated with CD39i in combination with anti-TIM3. H. Tumor volumes for untreated, anti-PD-1, CD39i and anti-PD-1+CD39i treated groups. I. Survival of B16-F10 tumor-bearing mice treated with CD39i + anti-PD-1. J. Tumor volumes for untreated, anti-PD-1/CTLA4, CD39i, anti-PD-1/CTLA4+CD39i. K. Survival of B16-F10 tumor-bearing mice treated with CD39i and anti-PD-1/CTLA4. Data are represented as mean±SEM. For in vivo mouse tumor models one of two independent experiments is shown.
Anti Tnfα Antibodies Ebioscience #88 7346, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/anti-tnfα antibodies ebioscience #88-7346/product/Thermo Fisher
Average 90 stars, based on 1 article reviews
anti-tnfα antibodies ebioscience #88-7346 - by Bioz Stars, 2026-05
90/100 stars
  Buy from Supplier

Image Search Results


A. Heatmap showing scaled expression values of discriminative gene sets between CD8_2 (exhaustion-like) and CD8_4+6 (memory/effector-like) using original unsorted, and sorted (CD39+TIM3+ and CD39−TIM3−) cells. B. Heatmap of scaled expression values of discriminative gene sets between sorted CD39+TIM3+CD8+ and CD39−TIM3−CD8+ T cells. Colored bars above heatmap show the CD8+ cluster (as in Figure 4A) in which the gene is enriched C. Representative flow cytometry plots for intracellular staining of IL-2, IFNγ and TNFα in CD39− and CD39+ cells, with quantification below for 12 patients. Data were combined from 2 replicate experiments. D. Quantification of live/dead cells based on staining of CT26GFP+ MDOTS on day 5 of ex vivo culture. One of two independent experiments is shown, with n=3 replicates per group per experiment. 2-way ANOVA, Tukey’s multiple comparisons test. E. A schematic summary of the therapy regimen used in the transplantable B16-F10 mouse model. F. Tumor volumes for all 4 groups. G. Survival of B16-F10 tumor-bearing mice treated with CD39i in combination with anti-TIM3. H. Tumor volumes for untreated, anti-PD-1, CD39i and anti-PD-1+CD39i treated groups. I. Survival of B16-F10 tumor-bearing mice treated with CD39i + anti-PD-1. J. Tumor volumes for untreated, anti-PD-1/CTLA4, CD39i, anti-PD-1/CTLA4+CD39i. K. Survival of B16-F10 tumor-bearing mice treated with CD39i and anti-PD-1/CTLA4. Data are represented as mean±SEM. For in vivo mouse tumor models one of two independent experiments is shown.

Journal: Cell

Article Title: Defining T cell states associated with response to checkpoint immunotherapy in melanoma

doi: 10.1016/j.cell.2018.10.038

Figure Lengend Snippet: A. Heatmap showing scaled expression values of discriminative gene sets between CD8_2 (exhaustion-like) and CD8_4+6 (memory/effector-like) using original unsorted, and sorted (CD39+TIM3+ and CD39−TIM3−) cells. B. Heatmap of scaled expression values of discriminative gene sets between sorted CD39+TIM3+CD8+ and CD39−TIM3−CD8+ T cells. Colored bars above heatmap show the CD8+ cluster (as in Figure 4A) in which the gene is enriched C. Representative flow cytometry plots for intracellular staining of IL-2, IFNγ and TNFα in CD39− and CD39+ cells, with quantification below for 12 patients. Data were combined from 2 replicate experiments. D. Quantification of live/dead cells based on staining of CT26GFP+ MDOTS on day 5 of ex vivo culture. One of two independent experiments is shown, with n=3 replicates per group per experiment. 2-way ANOVA, Tukey’s multiple comparisons test. E. A schematic summary of the therapy regimen used in the transplantable B16-F10 mouse model. F. Tumor volumes for all 4 groups. G. Survival of B16-F10 tumor-bearing mice treated with CD39i in combination with anti-TIM3. H. Tumor volumes for untreated, anti-PD-1, CD39i and anti-PD-1+CD39i treated groups. I. Survival of B16-F10 tumor-bearing mice treated with CD39i + anti-PD-1. J. Tumor volumes for untreated, anti-PD-1/CTLA4, CD39i, anti-PD-1/CTLA4+CD39i. K. Survival of B16-F10 tumor-bearing mice treated with CD39i and anti-PD-1/CTLA4. Data are represented as mean±SEM. For in vivo mouse tumor models one of two independent experiments is shown.

Article Snippet: The antibodies used for intracellular staining were FITC anti-human IFNγ (Miltenyi Biotec, 130–097-936), PE anti-human IL2 (Miltenyi Biotec, 130–099-391), APC anti-human TNFα (Miltenyi Biotec, 130–099-197), APC anti-mouse TNFα (Biolegend, 506307), PE anti-mouse IL2 (Biolegend, 503807), FITC anti-mouse IFNγ (Biolegend, 505805), PE anti-mouse Perforin-1 (Biolegend, 154305) and APC anti-mouse Granzyme-B (Biolegend, 372203).

Techniques: Expressing, Flow Cytometry, Staining, Ex Vivo, In Vivo

KEY RESOURCES TABLE:

Journal: Cell

Article Title: Defining T cell states associated with response to checkpoint immunotherapy in melanoma

doi: 10.1016/j.cell.2018.10.038

Figure Lengend Snippet: KEY RESOURCES TABLE:

Article Snippet: The antibodies used for intracellular staining were FITC anti-human IFNγ (Miltenyi Biotec, 130–097-936), PE anti-human IL2 (Miltenyi Biotec, 130–099-391), APC anti-human TNFα (Miltenyi Biotec, 130–099-197), APC anti-mouse TNFα (Biolegend, 506307), PE anti-mouse IL2 (Biolegend, 503807), FITC anti-mouse IFNγ (Biolegend, 505805), PE anti-mouse Perforin-1 (Biolegend, 154305) and APC anti-mouse Granzyme-B (Biolegend, 372203).

Techniques: Control, Purification, Recombinant, Multiplex Assay, Cell Viability Assay, RNA Sequencing, Sequencing, RNA Expression, Software